<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-043545</identifier>
<setSpec>0001-7310</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Treatment of severe refractory pemphigus vulgaris with rituximab</dc:title>
<dc:description xml:lang="en">Pemphigus vulgaris is a potentially fatal autoimmune bullous disease. High doses of immunosuppressive drugs are used in managing severe cases of pemphigus. Rituximab, an anti-CD20 monoclonal antibody, has proven to be effective in patients with refractory pemphigus vulgaris and pemphigus foliaceus. We review cases of pemphigus vulgaris and pemphigus foliaceus not associated with lymphoma that were treated with rituximab, and we report a new case of severe refractory pemphigus vulgaris successfully treated with rituximab</dc:description>
<dc:creator>Pardo, José</dc:creator>
<dc:creator>Torrijos, Arantxa</dc:creator>
<dc:creator>Sánchez-Carazo, José L</dc:creator>
<dc:creator>Roche, Elena</dc:creator>
<dc:creator>Fortea, José M</dc:creator>
<dc:creator>Pitarch, Gerard</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">El pénfigo vulgar es una enfermedad ampollosa autoinmune potencialmente mortal. En el tratamiento de los casos graves de pénfigo se utilizan fármacos inmunosupresores en dosis altas. Rituximab, un anticuerpo monoclonal anti-CD20, ha demostrado eficacia en pacientes con pénfigo vulgar y pénfigo foliáceo refractarios. Revisamos los casos de pénfigo vulgar y de pénfigo foliáceo tratados con rituximab no asociados a linfoma, y comunicamos un nuevo caso de pénfigo vulgar grave refractario tratado con éxito con rituximab</dc:description>
<dc:source>Actas Dermosifiliogr;97(1): 48-51, ene. 2006. ilus, tab</dc:source>
<dc:identifier>ibc-043545</dc:identifier>
<dc:title xml:lang="es">Tratamiento de pénfigo vulgar grave resistente con rituximab</dc:title>
<dc:subject>^d22164^s22038</dc:subject>
<dc:subject>^d308^s22073</dc:subject>
<dc:subject>^d22164^s22021</dc:subject>
<dc:subject>^d29312^s22016</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d3540^s22073</dc:subject>
<dc:subject>^d331</dc:subject>
<dc:subject>^d29503^s22012</dc:subject>
<dc:subject>^d13668^s22012</dc:subject>
<dc:subject>^d29503^s22057</dc:subject>
<dc:subject>^d7344^s22073</dc:subject>
<dc:subject>^d86^s22073</dc:subject>
<dc:subject>^d29510^s22045</dc:subject>
<dc:subject>^d29503^s22016</dc:subject>
<dc:subject>^d30164^s22073</dc:subject>
<dc:subject>^d1394^s22073</dc:subject>
<dc:subject>^d28169^s22073</dc:subject>
<dc:subject>^d920^s22073</dc:subject>
<dc:subject>^d9062</dc:subject>
<dc:subject>^d32748^s22045</dc:subject>
<dc:subject>^d1731^s22045</dc:subject>
<dc:subject>^d14171^s22073</dc:subject>
<dc:type>article</dc:type>
<dc:date>200601</dc:date>
</metadata>
</record>
</ibecs-document>
